Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
226.6 USD | +2.74% | +3.51% | +10.32% |
May. 30 | Transcript : Cencora, Inc. Presents at 2024 Leerink Partners Healthcare Crossroads Conference, May-30-2024 09:20 AM | |
May. 29 | Baird Adjusts Price Target on Cencora to $280 From $277 | MT |
Financials (USD)
Sales 2024 * | 290B | Sales 2025 * | 310B | Capitalization | 44.62B |
---|---|---|---|---|---|
Net income 2024 * | 2.01B | Net income 2025 * | 2.32B | EV / Sales 2024 * | 0.16 x |
Net Debt 2024 * | 1.24B | Net cash position 2025 * | 422M | EV / Sales 2025 * | 0.14 x |
P/E ratio 2024 * |
22.1
x | P/E ratio 2025 * |
18.9
x | Employees | 44,000 |
Yield 2024 * |
0.91% | Yield 2025 * |
0.93% | Free-Float | 58.3% |
Latest transcript on Cencora, Inc.
1 day | +2.74% | ||
1 week | +3.51% | ||
1 month | -5.22% | ||
3 months | -3.83% | ||
6 months | +11.41% | ||
Current year | +10.32% |
Managers | Title | Age | Since |
---|---|---|---|
Steven Collis
CEO | Chief Executive Officer | 62 | 93-12-31 |
James Cleary
DFI | Director of Finance/CFO | 61 | 15-01-31 |
Jennifer Dubas
CMP | Compliance Officer | - | 22-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kathleen Hyle
BRD | Director/Board Member | 65 | 10-05-12 |
Director/Board Member | 74 | 08-09-24 | |
D. Mark Durcan
BRD | Director/Board Member | 62 | 15-09-07 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.85% | 2 M€ | +21.73% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 226.6 | +2.74% | 3,835,641 |
24-05-30 | 220.5 | +0.67% | 2,127,897 |
24-05-29 | 219.1 | +1.32% | 1,773,984 |
24-05-28 | 216.2 | -1.22% | 1,400,875 |
24-05-24 | 218.9 | -0.42% | 1,029,855 |
Delayed Quote Nyse, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.32% | 44.62B | |
-7.16% | 178B | |
-4.86% | 67.04B | |
-4.28% | 47.24B | |
+8.14% | 42.5B | |
+15.76% | 29.99B | |
+15.53% | 25.22B | |
-5.88% | 24.14B | |
-5.38% | 23.69B | |
+1.38% | 22.04B |
- Stock Market
- Equities
- COR Stock